Gleiss Lutz advises EnviTec Biogas AG on its IPO and listing in the Prime Standard segment of the Frankfurt Stock Exchange

Gleiss Lutz advised EnviTec Biogas AG on its IPO and listing in the Prime Standard segment of the Frankfurt Stock Exchange. The company sees itself as the leading integrated provider of biogas facilities in Europe and covers the entire value chain for the production of biogas – including the planning, implementation and commissioning of biogas plants as well as the operation of its own biogas plants. In addition, EnviTec performs services relating to the operation and maintenance of biogas plants.

As part of a public offer in Germany and an international private placement, a bank consortium led by Dresdner Kleinwort placed 5,160,000 ordinary shares (including an over-allotment) at a price of EUR 47 per share. Of these, up to 3 million shares stem from a capital increase against cash contributions and 1,487,000 shares are from companies owned by the founding families. Further 673,000 shares were offered as part of an over-allotment from companies owned by the founding families, who retain a majority of shares in EnviTec Biogas AG following the IPO. The gross issue volume (including the over-allotment) amounted to approximately EUR 242,5 million. The shares of EnviTec Biogas AG are listed on the Official Market (Prime Standard) of the Frankfurt Stock Exchange as of July 12, 2007.

EnviTec Biogas AG was advised on its IPO by a team of Gleiss Lutz lawyers comprising partners Dr. Hoimar von Ditfurth and Dr. Stephan Aubel (joint lead), and lawyers Florian Metz and Michael Obst (all capital markets and corporate), Dr. Birgit Colbus (antitrust) and Stefan Köhler (tax).

In recent years, Gleiss Lutz advised clients on numerous IPOs and other share placements, including

· ersol Solar Energy AG on its capital increase
· Klöckner & Co. AG on its IPO
· Deutsche Bank on the IPOs of Bauer AG and ersol Solar Energy AG
· LBBW on the capital increase of MVV Energie AG
· SAF Simulation, Analysis and Forecasting AG, Schmack Biogas AG and MAGIX AG on their IPOs
· Ströher Finanzholding AG on the placement of shares of Q-Cells AG and related issuance of notes exchangeable by Credit Suisse